Back to search

Article

Nonglycemic Effects of SGLT2 Inhibitors: Focus on Inflammation and Macrophages

2024-11-08

Abstract excerpt

A growing body of evidences indicates that nonglycemic effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors play an important role in the protective effects of these drugs in diabetes, chronic kidney disease, and heart failure. In recent years, the anti-inflammatory potential of SGLT2 inhibitors has been actively studied. This review summarizes results of clinical and experimental studies on the anti-infla...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
144ec275-0088-53a6-9516-d5f6c936e20b
DOI
10.20944/preprints202411.0540.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nonglycemic Effects of SGLT2 Inhibitors: Focus on Inflammation and MacrophagesDOI 10.20944/preprints202411.0540.v1
Select a neighboring publication to make it the new centre.